Pharma Exec Accuses CFDA Officials Of Favoritism
This article was originally published in PharmAsia News
Executive Summary
An executive of two Chinese drug makers, Henan Yisheng Pharmaceuticals and its parent, Liaoning Yisheng Biological Pharmaceuticals, has joined with others to accuse three officials of the China FDA of wrongdoing.